Alessandro Castellarin
About
In The Last Decade
Alessandro Castellarin
39 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Ophthalmology 2.9k
- Radiology, Nuclear Medicine and Imaging 2.1k
- Molecular Biology 528
- Neurology 225
- Public Health, Environmental and Occupational Health 114
Countries citing papers authored by Alessandro Castellarin
This map shows the geographic impact of Alessandro Castellarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Castellarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Castellarin more than expected).
Fields of papers citing papers by Alessandro Castellarin
This network shows the impact of papers produced by Alessandro Castellarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Castellarin. The network helps show where Alessandro Castellarin may publish in the future.
Co-authorship network of co-authors of Alessandro Castellarin
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Castellarin. A scholar is included among the top collaborators of Alessandro Castellarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Castellarin. Alessandro Castellarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Treat and Extend Versus Bi-monthly dosing with Aflibercept for the Treatment of Diabetic Macular Edema, One Year Outcomes (EVADE Study) | 1 |
| 2 | 112 | |
| 3 | Comparison of Three Non-surgical Treatments for Vitreomacular Traction (VMT) | 1 |
| 4 | 32 | |
| 5 | Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT) | 1 |
| 6 | Outer Band Reflectivity Changes on SD-OCT Following Intravitreal Ocriplasmin for Vitreomacular Traction (VMT) and macular holes (MH) | 3 |
| 7 | Systemic Pharmacokinetics Following Intravitreal Injections of Ranibizumab, Bevacizumab or Aflibercept in Patients with DME | 2 |
| 8 | Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD breakdown → | 284 |
| 9 | 57 | |
| 10 | 18 | |
| 11 | Multicenter Study of Endophthalmitis After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents | 1 |
| 12 | 82 | |
| 13 | Ranibizumab for the Treatment of Macular Edema Associated With Perfused Central Retinal Vein Occlusions | 0 |
| 14 | Intravitreal Bevacizumab (Avastin®) in the Surgical Treatment of Proliferative Diabetic Retinopathy | 1 |
| 15 | 207 | |
| 16 | Open globe management. | 5 |
| 17 | 45 | |
| 18 | 86 | |
| 19 | 12 | |
| 20 | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.